Wen-Hung Chen, AstraZeneca

Lori D. McLeod, RTI Health Solutions

Regulatory and health technology assessment bodies increasingly recognize the value of incorporating patient perspectives during product development and evaluation. Patient experience data encompasses patient-reported outcomes, clinical assessments, and preference information, yet their integration into decision-making remains inconsistent. This collection seeks to advance understanding of how different stakeholders approach patient experience data to ensure patient voices meaningfully influence healthcare decisions.

The collection invites original research, reviews, and discussion papers examining how patient experience data—including preferences, symptoms, and quality of life measures—can inform regulatory and HTA submissions and decisions. Contributions addressing recent developments in the field and exploring emerging applications such as artificial intelligence and digital health technologies in patient experience research are particularly encouraged.

Appel publié par Quality of Life Research. Voir l'appel sur le site de l'éditeur. Fiche de l'appel sur kerostig.

Potential topics

• Assessment of patient experience, preferences, symptoms, and health-related quality of life for regulatory and HTA submissions
• Patient-reported outcomes and clinical outcome assessments in product development and evaluation
• Patient preference information collection and evaluation
• Artificial intelligence and digital health technology applications in patient experience data research
• Regulatory and HTA developments and decision-making processes
• Integration of patient voices in healthcare decisions to improve patient outcomes

Timeline

• June 30, 2027: Submission deadline